Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
-
Thi Thu Hien Nguyen
Abstract
Background: We examined antibodies against 60-, 65- and 70-kDa heat shock proteins (HSPs) in paediatric healthy individuals, patients with juvenile idiopathic arthritis (JIA) and those undergoing allogeneic stem-cell transplantation for various malignant and non-malignant diseases.
Methods: Western blotting and ELISA were used to examine HSP-directed humoral immune responses.
Results: Using ELISA we detected anti-Hsp60, -Hsp65 and -Hsp70 IgG antibodies in patient sera before, during and after conditioning and at all post-transplant times, as well as in JIA patients and controls. Western blotting showed positivity for anti-Hsp60 and anti-Hsp65 antibodies in all samples with a HSP concentration of 0.5μg/lane. However, anti-Hsp70 antibodies were not detected at all when both sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and native PAGE were used, except for one JIA patient, for whom a positive signal was only achieved in native PAGE when Hsp70 was increased to 2μg/lane and serum dilution decreased to 1:10.
Conclusion: Western blotting is convenient for the detection of anti-Hsp60 and anti-Hsp65 antibodies, but it is not sensitive enough for the detection of anti-Hsp70 antibodies. ELISA, which is more sensitive, might be preferentially used to screen anti-Hsp60, -Hsp65 and -Hsp70 antibodies in sera of children with various disorders.
References
1. Xiao C, Chen S, Yuan M, Ding F, Yang D, Wang R, et al. Expression of the 60-kDa and 71-kDa heat shock proteins and presence of antibodies against the 71-kDa heat shock protein in pediatric patients with immune thrombocytopenic purpura. BMC Blood Disorders 2004; 4:1.Search in Google Scholar
2. Schultz DR, Arnol PI. Heat shock (stress) proteins and autoimmunity in rheumatoid diseases. Semin Arthritis Rheum 1993; 22:357–74.10.1016/S0049-0172(05)80028-9Search in Google Scholar
3. Polla SB. A role for the heat shock proteins in inflammation? Immunol Today 1988; 9:134–7.10.1016/0167-5699(88)91199-1Search in Google Scholar
4. Feige U, van Eden W. Infection, autoimmunity and autoimmune disease. In: Feige U, Morimoto RI, Yahara I, Polla B, editors. Stress-inducible cellular responses. Basel: Birkhauser-Verlag, 1996:359–73.Search in Google Scholar
5. Conroy SE, Tucker L, Latchman DS, Isenberg DA. Incidence of anti Hsp90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis. Clin Exp Rheumatol 1996; 14:99–104.Search in Google Scholar
6. Bahr GM, Rook GA, al-Saffar M, Van Embden J, Stanford JL, Behbehani K. Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kDa heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol 1988; 74:211–5.Search in Google Scholar
7. Hayem G, De Bandt M, Palazzo E, Roux S, Combe B, Eliaou JF, et al. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58:291–6.10.1136/ard.58.5.291Search in Google Scholar
8. Hirata D, Hirai I, Iwamoto M, Yoshio T, Takeda A, Masuyama JI, et al. Preferential binding with Escherichia coli hsp60 of antibodies prevalent in sera from patients with rheumatoid arthritis. Clin Immunol Immunopathol 1997; 82:141–8.10.1006/clin.1996.4280Search in Google Scholar
9. De Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM, Kuis W, Van Der Zee R, Van Eden, et al. Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res 1993; 34:424–8.10.1203/00006450-199310000-00008Search in Google Scholar
10. Stevens TR, Winrow VR, Blake DR, Rampton DS. Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis. Clin Exp Immunol 1992; 90:271–4.10.1111/j.1365-2249.1992.tb07941.xSearch in Google Scholar
11. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 1995; 105:1347–52.10.1288/00005537-199512000-00016Search in Google Scholar
12. Shin SO, Billings PB, Keithley EM, Harris JP. Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Meniere's disease. Laryngoscope 1997; 107:222–7.10.1097/00005537-199702000-00015Search in Google Scholar
13. Paggi A, Di Prima MA, Paparo BS, Pellegrino C, Faralli AR, Sinopoli MT, et al. Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases. Endocr Res 1995; 21:555–67.10.3109/07435809509030473Search in Google Scholar
14. Shingai R, Maeda T, Onishi S, Yamamoto Y. Autoantibody against 70 kDa heat shock protein in patients with autoimmune liver diseases. J Hepatol 1995; 23:382–90.10.1016/0168-8278(95)80195-2Search in Google Scholar
15. Schaller JG. Rheumatic diseases of childhood. In: Nelson WE, Behrman RE, Kliegman RE, Arvin AM, editors. Nelson textbook of pediatrics, 15th ed. Philadelphia, PA: WB Saunders, 1996:657–91.Search in Google Scholar
16. Woo P, Wedderburn LR. Juvenile chronic arthritis. Lancet 1998; 351:969–73.10.1016/S0140-6736(05)60640-XSearch in Google Scholar
17. Kulas DT, Schanberg L. Juvenile idiopathic arthritis. Curr Opin Rheumatol 2001; 13:392–8.10.1097/00002281-200109000-00009Search in Google Scholar
18. Prakken AB, van Hoeij MJ, Kuis W, Kavelaars A, Heynen CJ, Scholtens E, et al. T-Cell reactivity to human hsp60 in oligo-articular juvenile chronic arthritis is associated with favourable prognosis and the generation of regulatory cytokines in the inflamed joint. Immunol Lett 1997; 57:139–42.10.1016/S0165-2478(97)00090-4Search in Google Scholar
19. De Kleer IM, Prakken BP, Albani S, Kuis W. The development of immune therapy with HSP60 for juvenile idiopathic arthritis. In: van Eden W, editor. Heat shock proteins and inflammation. Basel: Birkhäuser-Verlag, 2003:97–108.Search in Google Scholar
20. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25:1991–4.Search in Google Scholar
21. Prakken B, Kuis W, van Eden W, Albani S. Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr Rheumatol Rep 2002; 4:466–73.10.1007/s11926-002-0052-7Search in Google Scholar PubMed
22. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, et al. Bone marrow transplantation. N Engl J Med 1975; 292:832–43, 895–902.10.1056/NEJM197504242921706Search in Google Scholar PubMed
23. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285:412–5.10.1126/science.285.5426.412Search in Google Scholar PubMed
24. Jarvis M, Marzolini M, Wang XN, Jackson G, Sviland L, Dickinson AM. Heat shock protein 70: correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. Transplantation 2003; 7:849–53.10.1097/01.TP.0000083556.73555.78Search in Google Scholar PubMed
25. Goral J, Mathews HL, Clancy J Jr. Antibodies specific for the 70-kDa heat-shock protein parallel the development of acute graft-versus-host disease in (DA×LEW)F1 rats. Clin Immunol Immunopathol 1995; 75:147–53.10.1006/clin.1995.1064Search in Google Scholar PubMed
26. Goral J, Mathews HL, Clancy J Jr. Expression of 70-kDa heat-shock protein during acute graft-versus-host disease. Clin Immunol Immunopathol 1998; 86:252–8.10.1006/clin.1997.4473Search in Google Scholar PubMed
27. Goral J, Shenoy S, Mohanakumar T, Clancy J Jr. Antibodies to 70 kDa and 90 kDa heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients. Clin Exp Immunol 2002; 127:553–9.10.1046/j.1365-2249.2002.01770.xSearch in Google Scholar PubMed PubMed Central
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–5.10.1038/227680a0Search in Google Scholar
29. Calandrella M, Matteucci D, Mazzetti D, Poli A. Densitometric analysis of Western blot assays for feline immunodeficiency virus antibodies. Vet Immunol Immunopathol 2001; 79:261–71.10.1016/S0165-2427(01)00265-3Search in Google Scholar
30. Ornstein L. Disc electrophoresis. I. Background and theory. Ann NY Acad Sci 1964; 121:321–49.10.1111/j.1749-6632.1964.tb14207.xSearch in Google Scholar
31. Rea IM, McNerlan S, Pockley AG. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol 2001; 36:341–52.10.1016/S0531-5565(00)00215-1Search in Google Scholar
32. Alcantara FF, Iglehart DJ, Ochs RL. Heparin in plasma samples causes non-specific binding to histones on Western blots. J Immunol Methods 1999; 226:11–8.10.1016/S0022-1759(99)00043-5Search in Google Scholar
33. Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Antigen recognition by B-cell and T-cell receptors. In: Immunobiology, 6th ed. New York: Garland Science, 2005:103–34.Search in Google Scholar
34. Munari L, Charchat S, Rodrigues L, von Muhlen CA, Bau AR, Lavinsky L, et al. An ELISA serum assay for autoantibodies to HSP70 in immune-mediated hearing loss. J Immunol Methods 2004; 283:155–61.10.1016/j.jim.2003.09.008Search in Google Scholar
35. Kurien BT, Scofield RH. Protein blotting: a review. J Immunol Methods 2003; 274:1–15.10.1016/S0022-1759(02)00523-9Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Natriuretic peptides and evidence-based quality specifications
- Preanalytical variability: the dark side of the moon in laboratory testing
- Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
- Hepatorenal syndrome
- Modified Levey-Jennings charts for calculated laboratory tests
- Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
- The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
- Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores
- Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
- Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
- Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
- Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
- Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
- Pyrosequencing protocol requiring a unique biotinylated primer
- Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
- Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
- Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
- Stepwise strategies in analysing haematuria and leukocyturia in screening
- Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
- Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
- Release of anandamide from blood cells
- Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
- Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
- Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
- Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
- Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
- The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
- Is cystatin C a reliable renal marker in trauma?
- On the independence of intraindividual reference values
- Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006
Articles in the same Issue
- Natriuretic peptides and evidence-based quality specifications
- Preanalytical variability: the dark side of the moon in laboratory testing
- Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
- Hepatorenal syndrome
- Modified Levey-Jennings charts for calculated laboratory tests
- Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
- The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
- Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores
- Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
- Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
- Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
- Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
- Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
- Pyrosequencing protocol requiring a unique biotinylated primer
- Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
- Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
- Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
- Stepwise strategies in analysing haematuria and leukocyturia in screening
- Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
- Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
- Release of anandamide from blood cells
- Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
- Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
- Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
- Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
- Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
- The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
- Is cystatin C a reliable renal marker in trauma?
- On the independence of intraindividual reference values
- Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006
